- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Nodular Lymphocyte Predominant B-Cell Lymphoma in New Zealand
Total 826 results
-
Celldex TherapeuticsCompletedMantle Cell Lymphoma | Chronic Lymphocytic Leukemia | CD27 Expressing B-cell Malignancies for Example Hodgkin's Lymphoma | Marginal Zone B Cell Lymphoma) | Any T-cell Malignancy | Solid Tumors (Metastatic Melanoma, Renal (Clear) Cell Carcinoma | Hormone-refractory Prostate Adenocarcinoma, Ovarian... and other conditionsUnited States
-
US Oncology ResearchAstex Pharmaceuticals, Inc.CompletedB-Cell Chronic Lymphocytic LeukemiaUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)WithdrawnRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Recurrent Burkitt Lymphoma | Refractory Burkitt... and other conditionsUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
Northwell HealthCompletedChronic Lymphocytic LeukemiaUnited States
-
Northwell HealthCompletedChronic Lymphocytic LeukemiaUnited States
-
Dartmouth-Hitchcock Medical CenterAmerican Cancer Society, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
MorphoSys AGIqvia Pty LtdRecruitingDiffuse Large B-cell LymphomaUnited States
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, Korea, Republic of, United Kingdom, Taiwan, Israel, Spain, Australia, France
-
Nordic Lymphoma GroupRoche Pharma AGRecruitingDiffuse Large B Cell Lymphoma | DLBCLFinland, Norway, Denmark, Italy, Sweden, Australia, New Zealand
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Memorial Sloan Kettering Cancer CenterCelgene CorporationCompletedLeukemia | Chronic Lymphocytic LeukemiaUnited States
-
AstraZenecaRecruitingFollicular Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | B-cell Non Hodgkin LymphomaKorea, Republic of, United States, Japan, Taiwan, Australia
-
Janssen Research & Development, LLCPharmacyclics LLC.RecruitingLeukemia, Lymphocytic, Chronic, B-Cell | Small Lymphocytic LymphomaUnited States, Italy, Poland, Spain, Czechia
-
Gilead SciencesTerminatedB-cell Chronic Lymphocytic Leukemia (CLL) With 17p DeletionUnited States, Spain, Denmark, Belgium, Australia, Poland, Romania, Czechia, Italy, France, Hungary, Austria, Portugal, United Kingdom
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
All India Institute of Medical Sciences, New DelhiUnknownChronic Lymphocytic LeukemiaIndia
-
Memorial Sloan Kettering Cancer CenterColumbia University; Genentech, Inc.Completed
-
Acerta Pharma BVActive, not recruitingChronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Small Lymphocytic Lymphoma | Richter's SyndromeUnited States, United Kingdom, Italy
-
KineMedChronic Lymphocytic Leukemia Research ConsortiumCompletedChronic Lymphocytic LeukemiaUnited States
-
Epizyme, Inc.CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Advanced Solid Tumor | Diffuse Large B Cell Lymphoma | Primary Mediastinal LymphomaUnited States
-
Genta IncorporatedCompleted
-
John ReneauRecruitingT-Cell Large Granular Lymphocyte LeukemiaUnited States
-
Northwell HealthRecruitingAtrial Fibrillation | Chronic Lymphocytic Leukemia | Ventricular Arrhythmias and Cardiac Arrest | Supraventricular Arrhythmia | Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaUnited States
-
Dartmouth-Hitchcock Medical CenterWithdrawnChronic Lymphocytic LeukemiaUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Hodgkin Lymphoma | Refractory Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
University of RochesterRecruiting
-
Roswell Park Cancer InstituteCelgeneCompleted
-
Yale UniversityCelgene CorporationTerminatedChronic Lymphocytic LeukemiaUnited States
-
Roswell Park Cancer InstituteCompleted
-
Pharmacyclics LLC.Janssen, LPCompletedChronic Lymphocytic Leukemia (CLL)United States
-
Memorial Sloan Kettering Cancer CenterNorthwestern University; Merck Sharp & Dohme LLC; Weill Medical College of Cornell... and other collaboratorsCompletedLymphoma | Hodgkin's DiseaseUnited States
-
Juno Therapeutics, a Subsidiary of CelgeneCompletedLymphoma Non-Hodgkin | Agressive Lymphoma | Diffuse-large B-cell Lymphoma (DLBCL)United States, Canada
-
TG Therapeutics, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
Janssen Research & Development, LLCActive, not recruitingLymphoma, Non-Hodgkin | Leukemia, Lymphocytic, Chronic, B-CellUnited States, Korea, Republic of, Israel, Japan, Germany, Spain, Australia, China, France, United Kingdom, Greece, Italy
-
Memorial Sloan Kettering Cancer CenterMassachusetts General Hospital; BeiGene USA, Inc.; Roche-GenentechRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Leukemia (SLL)United States
-
Idera Pharmaceuticals, Inc.CompletedDiffuse Large B Cell LymphomaUnited States
-
BiogenCompletedChronic Lymphocytic LeukemiaUnited States
-
Hoffmann-La RocheCompletedDiffuse Large B-cell Lymphoma | High-Grade B-cell LymphomaUnited States, Spain, Australia, Denmark
-
MedImmune LLCCompletedRelapsed/Refractory Aggressive B-cell LymphomasUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States, Israel
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
New York Medical CollegeCompletedAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | Acute Myelogenous Leukemia | Diffuse Large B-cell Lymphoma | Burkitt Lymphoma/LeukemiaUnited States
-
Adicet Bio, IncRecruitingLymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-Cell | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal B-cell LymphomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Alexion PharmaceuticalsTerminatedMultiple Myeloma | B-cell Chronic Lymphocytic LeukemiaUnited States
-
Sutro Biopharma, Inc.Active, not recruitingFollicular Lymphoma | B-cell Lymphoma | Multiple Myeloma | Mantle Cell Lymphoma | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | Indolent Lymphoma | B Cells--TumorsUnited States
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy
-
Seagen Inc.TerminatedNon-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma | DLBCL | Grade 3 Follicular LymphomaUnited States